Eriacta, comprising Sildenafil Citrate and identifiable by its distinctive blue tablets, is a pharmacotherapeutic agent employed in the management of erectile dysfunction (ED). The administration of this medication requires meticulous consideration, particularly in the context of patients presenting with advanced cardiovascular pathologies.

Reviewer Keywords